Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02749 (
beta2-glycoprotein I
)
836
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
beta2-Glycoprotein I was shown to bind reversibly to calmodulin in a Ca2+-dependent manner with a 1:1 stoichiometry, a Kd of 3 x 10(-9) M and a Hill coefficient of 1.4. A sequence in
beta2-glycoprotein I
(Lys-Pro-Gly-Tyr-Val-Ser-Arg-Gly-Gly-
Met
-Arg-Lys-Phe-Ile-) limited by Cys-32 and Cys-47 is suggested to be the calmodulin-binding region. This sequence was the only one in
beta2-glycoprotein I
theoretically having the ability to form a basic amphiphilic alpha-helix typical of a calmodulin binding sequence. The peptide corresponding to this sequence was synthesized and found to inhibit the interaction between
beta2-glycoprotein I
and calmodulin with an IC50 value of 0.38 x [
beta2-glycoprotein I
] and to displace the
beta2-glycoprotein I
from the
beta2-glycoprotein I
/calmodulin complex with an IC50 value of 0.90 x [
beta2-glycoprotein I
].
...
PMID:Characterization of the interaction between beta2-glycoprotein I and calmodulin, and identification of a binding sequence in beta2-glycoprotein I. 918 41